| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/06/2001 | EP1104309A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/06/2001 | EP1104293A1 Regulation of substrate activity |
| 06/06/2001 | EP1104291A1 Pellets having a core coated with an antifungal and a polymer |
| 06/06/2001 | EP0768887B1 Compositions having antiviral properties and preparation process |
| 06/06/2001 | EP0741728B1 Improved process for synthesizing carbapenem intermediates |
| 06/06/2001 | EP0690865B1 Crystalline benzathine salt of cefonicid and its preparation |
| 06/06/2001 | EP0673426B1 Platelet-activating factor acetylhydrolase |
| 06/06/2001 | EP0536299B1 Surface complexed lymphotoxin |
| 06/06/2001 | CN1298446A Vaccines containing recombinant pilin against i cneisseria gonorrhoeae (or i cneisseria meningitidis) |
| 06/06/2001 | CN1298310A Stable mitoxantron solutions |
| 06/06/2001 | CN1298307A Enhancement of immunity by intranasal inoculation of IL-12 |
| 06/06/2001 | CN1298302A Topical administration of oxazolidinones for transdermal delivery |
| 06/06/2001 | CN1298299A Antibacterial agents |
| 06/06/2001 | CN1297768A Medicated cigarette for treating pulmonary tuberculosis and its making process |
| 06/06/2001 | CN1297736A AIDS resisting medicine and its application |
| 06/06/2001 | CN1066735C Cephalosporin antibiotics |
| 06/06/2001 | CN1066728C Process for producing epoxide |
| 06/05/2001 | US6242578 Glycoconjugate of carbohydrate covalently bound to peptide of defined amino acid sequence; prevention of influenza virus binding to cells, treatment of schizophrenia, and diagnosis of chronic viral diseases related to cancer |
| 06/05/2001 | US6242566 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/05/2001 | US6242473 Administering histamine |
| 06/05/2001 | US6242461 Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases |
| 06/05/2001 | US6242459 Substituted bis-acridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 06/05/2001 | US6242457 Oxime derivatives |
| 06/05/2001 | US6242439 Azetidinone derivatives for the treatment of HCMV infections |
| 06/05/2001 | US6242437 Cephem derivatives |
| 06/05/2001 | US6242429 Antiviral ara-a derivatives having resistance to metabolism by adenosinedeaminase |
| 06/05/2001 | US6242428 Nucleosides and nucleoside dimers containing an l-sugar in at least one of the nucleosides |
| 06/05/2001 | US6242419 Genes encoding proteins expressed in lymph node stromal cells from flaky skin (fsn-/-) mice and their use in therapy. |
| 06/05/2001 | US6242418 Therapeutic uses of BPI protein products for human meningococcemia |
| 06/05/2001 | US6242255 Protein which induces interferon-gamma production by immunocompetent cell |
| 06/05/2001 | US6242250 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 06/05/2001 | US6242249 Nucleotide sequences of trigger factor chaperones from staphylococcus; diagnosis; probes; primers; vaccines; bactericides; bacteriostats; antibodies; drug screening |
| 06/05/2001 | US6241990 Immunogenic composition containing inactivated swine infertility and respiratory Syndrome virus |
| 06/05/2001 | CA2034592C Crystalline hydrochloride of new beta-lactam antibiotic and process therefor |
| 06/03/2001 | CA2327385A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/03/2001 | CA2327256A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038548A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/31/2001 | WO2001038538A1 Polymerase compositions and methods of use thereof |
| 05/31/2001 | WO2001038503A2 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | WO2001038499A1 Membrane virus host range mutations and their uses as vaccine substrates |
| 05/31/2001 | WO2001038497A1 Duck pneumovirus and corresponding vaccines |
| 05/31/2001 | WO2001038397A1 N-alkylated peptides having antiangiogenic activity |
| 05/31/2001 | WO2001038362A2 Production of vaccines |
| 05/31/2001 | WO2001038361A1 Modified adenovirus fibre and uses |
| 05/31/2001 | WO2001038360A2 Novel hcv non-structural polypeptide |
| 05/31/2001 | WO2001038358A2 Hbv/hcv virus-like particle |
| 05/31/2001 | WO2001038350A2 85kDa NEISSERIAL ANTIGEN |
| 05/31/2001 | WO2001038340A1 Method of preparing clarithromycin |
| 05/31/2001 | WO2001038338A1 Synthetic oligomannosides, preparation and uses thereof |
| 05/31/2001 | WO2001038332A1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | WO2001038320A1 Vitamin d analogues |
| 05/31/2001 | WO2001038315A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 05/31/2001 | WO2001038314A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 05/31/2001 | WO2001038313A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p39 kINASE INHIBITORS |
| 05/31/2001 | WO2001038312A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001038311A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | WO2001038305A2 Novel il-8 receptor antagonists |
| 05/31/2001 | WO2001038302A2 Coupling condensation synthesis of heterocycles |
| 05/31/2001 | WO2001037890A1 A propellant free spray-on skin patch composition for improving wound healing and for drug administration |
| 05/31/2001 | WO2001037881A2 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 05/31/2001 | WO2001037869A1 Vaccine compositions |
| 05/31/2001 | WO2001037868A1 Assays and therapies for latent viral infection |
| 05/31/2001 | WO2001037863A2 Compositions comprising neisseria meningitidis antigens from serogroups b and c as well as a further antigen |
| 05/31/2001 | WO2001037862A2 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias |
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037846A1 Method and composition for the treatment of adenoviral ocular infections |
| 05/31/2001 | WO2001037843A1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 05/31/2001 | WO2001037837A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001037830A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 05/31/2001 | WO2001037828A1 Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases |
| 05/31/2001 | WO2001037823A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 05/31/2001 | WO2001037821A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 05/31/2001 | WO2001037819A2 Use of indirubine derivatives for making medicines |
| 05/31/2001 | WO2001037816A2 Coating of tablet cores |
| 05/31/2001 | WO2001037815A1 Osmotic dosage form comprising first and second |
| 05/31/2001 | WO2001037808A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | WO2001037667A1 Combination of n-phenyl-n'-benzoyl urea derivative and nectin compounds for parasite control |
| 05/31/2001 | WO2001009186A3 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
| 05/31/2001 | WO2000077188A3 Dna pcv vaccine |
| 05/31/2001 | WO2000071555A3 509rr |
| 05/31/2001 | WO2000071140A3 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 05/31/2001 | WO2000063222A3 Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments |
| 05/31/2001 | WO2000061754A3 Human proteins and polynucleotides encoding them |
| 05/31/2001 | WO2000050072A3 Method for the purification, recovery, and sporulation of cysts and oocysts |
| 05/31/2001 | WO2000047194A9 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 05/31/2001 | WO2000042071A3 Compounds and methods to inhibit or augment an inflammatory response |
| 05/31/2001 | WO2000032196A3 Inhibitors of multidrug transporters |
| 05/31/2001 | WO2000009512A3 Bipyridine manganese complexes |
| 05/31/2001 | US20010002400 Administering an antifungal agent |
| 05/31/2001 | US20010002256 Multicomponent clostridial vaccines using saponin adjuvants |
| 05/31/2001 | CA2762106A1 Compositions comprising neisseria meningitidis antigens from serogroups b and c |
| 05/31/2001 | CA2706113A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | CA2395049A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | CA2394803A1 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | CA2392527A1 Hbv/hcv virus-like particle |
| 05/31/2001 | CA2392468A1 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 05/31/2001 | CA2392456A1 Assays and therapies for latent viral infection |